Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme targets, enhancing drug efficacy. Commonly employed in research settings to design compounds with improved metabolic stability and bioavailability. Also utilized in the preparation of novel heterocyclic systems for screening in drug discovery programs.